Comprehensive Metabolic Panel Testing Market Size 2025-2029
The comprehensive metabolic panel testing market size is forecast to increase by USD 5.8 billion, at a CAGR of 8.6% between 2024 and 2029.
The global comprehensive metabolic panel testing market is expanding, driven by the escalating prevalence of chronic diseases that require regular monitoring for effective management. This creates a sustained need for metabolic screening panels that provide a broad overview of a patient's health status. Innovations in metabolomics and direct to consumer laboratory testing are making these diagnostics more accessible. The shift toward point-of-care testing offers rapid results critical for immediate clinical decisions, aligning with the needs of the point of care glucose testing market. These platforms streamline patient management and improve outcomes in various healthcare settings by enabling timely interventions based on real-time metabolic data.The growth trajectory is supported by the increasing adoption of point-of-care solutions, which decentralize diagnostics from traditional laboratories to near-patient settings. However, stringent regulatory frameworks and complex compliance burdens for in-vitro diagnostic tests pose a significant challenge. These regulations, designed to ensure patient safety and test accuracy, can delay market entry for new technologies and increase operational costs for manufacturers. Navigating these evolving requirements demands significant resources and expertise, impacting both established players and new entrants in the continuous glucose monitoring (CGM) market and the broader diagnostics field, including biopharmaceutical analytical testing services.
What will be the Size of the Comprehensive Metabolic Panel Testing Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The global comprehensive metabolic panel testing market is characterized by a dynamic interplay between technological innovation and evolving healthcare needs. The integration of digital health platforms with at-home sample collection and direct to consumer laboratory testing is decentralizing diagnostics and empowering patients. Advancements in biosensor technology and microfluidics applications are enabling the development of more sophisticated point-of-care solutions, which are crucial in the broader point of care glucose testing market. These shifts are reshaping clinical workflows and creating new models for chronic disease management and preventive health screening, focusing on accessibility and rapid turnaround times for critical metabolic data.Regulatory and reimbursement landscapes continue to shape market access and commercialization strategies. Navigating the complexities of in-vitro diagnostic regulation (IVDR) and clinical laboratory improvement amendments (CLIA) remains a central focus for manufacturers. Simultaneously, the push for value-based care models requires demonstrating the clinical utility and cost-effectiveness of routine metabolic screening. The expansion of biopharmaceutical analytical testing services is also influencing the demand for more specialized and sensitive assays, pushing the boundaries of what can be achieved with metabolic panel analysis and creating new avenues for research and development in diagnostic technologies.
How is this Comprehensive Metabolic Panel Testing Industry segmented?
The comprehensive metabolic panel testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Application
- Kidney diseases
- Diabetes
- Liver diseases
- Others
- Test
- Kidney function tests
- Glucose
- Liver function tests
- Electrolytes
- Others
- End-user
- Laboratories
- Hospital
- Point-of-care testing
- Emergency departments
- Others
- Geography
- North America
- Asia
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
- Rest of World (ROW)
By Application Insights
The kidney diseases segment is estimated to witness significant growth during the forecast period.
The comprehensive metabolic panel testing market is significantly driven by its application in managing kidney diseases. A primary catalyst is the escalating global prevalence of chronic kidney disease, a condition common among the aging population. The comprehensive metabolic panel provides critical information on kidney function through analytes like blood urea nitrogen and creatinine, making it indispensable for monitoring. The fact that nine in ten older adults report having one or more chronic conditions underscores the importance of this testing.
Therapeutic advancements are also influencing this segment. For instance, the expanded use of certain medications for diabetes has shown significant renal protective benefits, necessitating more frequent metabolic monitoring to assess efficacy and manage potential side effects. This trend reinforces the comprehensive metabolic panel's role as a cornerstone of diagnostic and monitoring strategies, particularly given the intricate interplay between diabetes, cardiovascular conditions, and kidney disease in patient management.
Request Free Sample
The Kidney diseases segment was valued at USD 3.1 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 40.0% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
North America holds a commanding share of the global comprehensive metabolic panel testing market, a position supported by its advanced healthcare infrastructure and a proactive approach to preventive care. The high prevalence of chronic diseases is a primary driver, with nearly half of all adults in some areas presenting with a form of cardiovascular disease. This necessitates regular metabolic monitoring for a large segment of the population. The region's market is also characterized by extensive insurance coverage for diagnostic testing.
An aging demographic in North America further fuels demand, making the comprehensive metabolic panel an essential tool in managing age-related health conditions. The region is also at the forefront of adopting technological innovations, including point-of-care diagnostics and new testing portfolios for weight management. This convergence of high disease burden, technological leadership, and a supportive, albeit evolving, regulatory framework solidifies North America's leading position and points toward sustained growth in the comprehensive metabolic panel testing market.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global comprehensive metabolic panel testing market is expanding, largely due to the impact of chronic diseases on CMP testing. Key drivers include the use of the comprehensive metabolic panel for diabetes management and the comprehensive metabolic panel for kidney disease, in addition to monitoring liver function with metabolic panels. Its application is vital for electrolyte monitoring in critical care settings and the comprehensive metabolic panel in geriatric care. While the cost-effectiveness of routine metabolic screening is a significant advantage, the industry faces reimbursement challenges for diagnostic panels. Concurrently, technological advancements in laboratory automation are essential for handling high test volumes and for integrating CMP results with electronic health records, which aids in developing new biomarkers for metabolic diseases.Emerging trends in decentralized diagnostic testing are reshaping the landscape, fostering growth in point of care testing for metabolic disorders and direct to consumer metabolic health testing. This shift requires navigating complex regulatory frameworks for in-vitro diagnostic tests. The impact of IVDR on diagnostic manufacturers and the necessity of navigating CLIA regulations for POC tests are critical considerations. Innovation is also a focal point, emphasizing the role of AI in metabolic panel analysis and advancements in non-invasive metabolic monitoring. However, this evolution raises data privacy concerns in at-home testing, which must be addressed to maintain consumer confidence and market integrity.
What are the key market drivers leading to the rise in the adoption of Comprehensive Metabolic Panel Testing Industry?
- The persistent and escalating prevalence of chronic, lifestyle-associated diseases is a key driver for the market.
The persistent and escalating prevalence of chronic, lifestyle-associated diseases is a primary driver for the comprehensive metabolic panel testing market. Conditions such as diabetes and cardiovascular disorders require regular monitoring to manage patient health and mitigate complications, creating sustained demand for cmp testing. These metabolic screening panels serve as a foundational diagnostic tool for clinicians to assess organ function and metabolic status, which are critical in the longitudinal management of these long-term illnesses. In some regions, nearly half of all adults present some form of cardiovascular disease, a figure that continues to drive demand for comprehensive diagnostic workups and glycemic control monitoring.The demographic shift toward an older global population represents a fundamental driver for the market. Elderly individuals are physiologically more susceptible to developing chronic metabolic disorders, necessitating more frequent and thorough health screenings as a cornerstone of geriatric medicine. This increased vulnerability positions the cmp as a critical instrument for early detection and ongoing management of age-related conditions. As individuals age, the likelihood of having multiple comorbidities rises, making the comprehensive overview provided by a cmp invaluable. The fact that nine in ten older adults report one or more chronic conditions solidifies the role of routine metabolic screening in standard geriatric care protocols.
What are the market trends shaping the Comprehensive Metabolic Panel Testing Industry?
- The ascendancy of point-of-care metabolic panel testing is a significant upcoming trend in the market.
The global comprehensive metabolic panel testing market is experiencing a significant shift with the development and adoption of point-of-care solutions. This transition from centralized laboratory testing to decentralized, near-patient analysis is driven by the demand for rapid results, crucial in emergency settings and outpatient clinics for immediate clinical decision-making. This trend, which is transforming the point of care glucose testing market, streamlines patient management and reduces the time to diagnosis. The introduction of portable and user-friendly devices is particularly beneficial in remote and underserved areas, enhancing access to essential diagnostics. The market opportunity is significant, with one region alone representing nearly 40% of potential growth.The integration of artificial intelligence and machine learning algorithms represents a transformative trend within the market. These advanced analytical tools, central to the evolution of metabolomics, are increasingly used to enhance the speed, accuracy, and predictive power of diagnostic testing. Ai can analyze large, complex datasets from metabolic panels to identify subtle patterns that may not be apparent to the human eye, revolutionizing early disease detection and personalized treatment plans. While the focus of rapid microbiology testing market is different, the underlying principle of leveraging technology for faster, more accurate results is a shared dynamic across the diagnostics industry. This move toward smarter, predictive diagnostic tools is a significant factor in market evolution.
What challenges does the Comprehensive Metabolic Panel Testing Industry face during its growth?
- Stringent regulatory frameworks and compliance burdens present a key challenge affecting industry growth.
The global comprehensive metabolic panel testing market faces a significant challenge from increasingly stringent and complex regulatory frameworks, including in-vitro diagnostic regulation (IVDR) and clinical laboratory improvement amendments (CLIA). These evolving regulations impose substantial compliance burdens on manufacturers and laboratories, potentially impeding market growth and innovation. The need to secure oversight from a limited number of designated notified bodies results in extended timelines and increased costs for bringing new or updated tests to market. This regulatory uncertainty can deter smaller manufacturers and may lead to the discontinuation of certain existing tests, thereby reducing the availability of diagnostic options and affecting the supply of metabolic screening panels.The financial viability of comprehensive metabolic panel testing is heavily influenced by intricate and restrictive reimbursement policies. In some markets, reimbursement is subject to strict medical necessity criteria, limiting the use of these panels for routine preventive screening and capping a significant potential market. With one region contributing 40.0% of the market's incremental growth, navigating its specific payer requirements is critical. The trend toward value-based care models also pressures laboratories to demonstrate the cost-effectiveness of testing. A lack of established and harmonized reimbursement pathways across key markets presents a significant hurdle for the widespread adoption and commercial success of both routine and advanced diagnostic solutions.
Exclusive Customer Landscape
The comprehensive metabolic panel testing market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the comprehensive metabolic panel testing market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, comprehensive metabolic panel testing market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - Offerings include comprehensive metabolic panel testing through integrated core laboratory solutions, providing a range of assays designed to assess liver, kidney, heart, and overall metabolic function. These panels are processed on automated clinical chemistry analyzers that consolidate multiple tests, supporting efficient and high-throughput screening. The tests measure key analytes from plasma or serum samples, including glucose, calcium, electrolytes, enzymes, and proteins, delivering a broad overview of a patient's metabolic status. This capability is central to routine health screenings, chronic disease management, and critical care diagnostics, enabling clinicians to make timely and informed decisions based on a holistic view of organ system function.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Abbott Laboratories
- ARUP Laboratories
- Beckman Coulter Inc.
- Bio Rad Laboratories Inc.
- CENTOGENE NV
- DiaSorin Spa
- F. Hoffmann La Roche Ltd.
- Laboratory Corp.
- Mayo Medical Laboratories
- Metropolis Healthcare Ltd.
- Quest Diagnostics Inc.
- QuidelOrtho Corp.
- Randox Laboratories Ltd.
- Siemens Healthineers AG
- Sonic Healthcare Ltd.
- SYNLAB International GmbH
- Thermo Fisher Scientific Inc.
- Unipath Specialty Laboratory Ltd.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Comprehensive Metabolic Panel Testing Market
In June 2024, Abbott announced it received clearance from the U.S. Food and Drug Administration for its Lingo and Libre Rio over-the-counter continuous glucose monitoring systems, expanding consumer access to metabolic health data.In May 2024, Siemens Healthineers and Google Cloud announced an expansion of their partnership to accelerate the development of AI-powered solutions for healthcare, including applications in diagnostics to assist clinicians with data interpretation.In March 2024, Roche launched its Digital LightCycler System, a next-generation digital polymerase chain reaction (PCR) system designed to provide absolute quantification in life science research and diagnostics for oncology and infectious diseases.In March 2024, Labcorp introduced a new weight loss management portfolio, featuring a baseline test to assess metabolic function, aimed at individuals considering GLP-1 medications.
Research Analyst Overview
The global comprehensive metabolic panel testing market utilizes sophisticated in-vitro diagnostic tests and clinical chemistry analyzers for metabolic dysfunction analysis and electrolyte imbalance detection. These processes are essential for monitoring key kidney function markers, such as blood urea nitrogen and creatinine measurement, and for performing liver enzyme analysis as part of hepatic function tests. The evaluation of serum protein levels, calcium homeostasis, and acid-base balance assessment offers a holistic view of patient health. Evolving laboratory automation and biosensor technology, alongside microfluidics applications, continuously refine renal function evaluation, enhancing the capabilities of both centralized labs and point-of-care diagnostics settings with greater precision and efficiency.New models of care are transforming the market landscape through the adoption of telehealth integration and remote patient monitoring, supported by digital health platforms. The expansion of direct-to-consumer testing, including at-home sample collection and handheld analyzers, reflects a move toward greater patient involvement, with developments in non-invasive diagnostics showing further potential. AI-powered diagnostics and machine learning algorithms are enhancing predictive analytics in healthcare, aiding in biomarker discovery. This evolution occurs within a framework governed by clinical laboratory improvement amendments and in-vitro diagnostic regulation, where reimbursement policies and medical necessity criteria are critical. The industry is expected to expand by over 4% while maintaining a focus on data privacy in diagnostics.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Comprehensive Metabolic Panel Testing Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
310
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 8.6%
|
|
Market growth 2024-2029
|
USD 5.8 billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
7.9%
|
|
Key countries
|
US, Canada, Mexico, China, India, Japan, South Korea, Indonesia, Thailand, Singapore, Germany, UK, France, Italy, The Netherlands, Spain, Russia, Australia, Brazil, UAE, South Africa, Saudi Arabia, Turkey
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Comprehensive Metabolic Panel Testing Market Research and Growth Report?
- CAGR of the Comprehensive Metabolic Panel Testing industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Asia, Europe, Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the comprehensive metabolic panel testing market growth of industry companies
We can help! Our analysts can customize this comprehensive metabolic panel testing market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Test
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Comprehensive Metabolic Panel Testing Market 2019 - 2023
- Historic Market Size - Data Table on Global Comprehensive Metabolic Panel Testing Market 2019 - 2023 ($ billion)
- 5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
- 5.3 Test segment analysis 2019 - 2023
- Historic Market Size - Test Segment 2019 - 2023 ($ billion)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 Impact of AI in global comprehensive metabolic panel testing market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
- 8 Market Segmentation by Application
- 8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 8.3 Kidney diseases - Market size and forecast 2024-2029
- Chart on Kidney diseases - Market size and forecast 2024-2029 ($ billion)
- Data Table on Kidney diseases - Market size and forecast 2024-2029 ($ billion)
- Chart on Kidney diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Kidney diseases - Year-over-year growth 2024-2029 (%)
- 8.4 Diabetes - Market size and forecast 2024-2029
- Chart on Diabetes - Market size and forecast 2024-2029 ($ billion)
- Data Table on Diabetes - Market size and forecast 2024-2029 ($ billion)
- Chart on Diabetes - Year-over-year growth 2024-2029 (%)
- Data Table on Diabetes - Year-over-year growth 2024-2029 (%)
- 8.5 Liver diseases - Market size and forecast 2024-2029
- Chart on Liver diseases - Market size and forecast 2024-2029 ($ billion)
- Data Table on Liver diseases - Market size and forecast 2024-2029 ($ billion)
- Chart on Liver diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Liver diseases - Year-over-year growth 2024-2029 (%)
- 8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
9 Market Segmentation by Test
- 9 Market Segmentation by Test
- 9.1 Market segments
- Chart on Test - Market share 2024-2029 (%)
- Data Table on Test - Market share 2024-2029 (%)
- 9.2 Comparison by Test
- Chart on Comparison by Test
- Data Table on Comparison by Test
- 9.3 Kidney function tests - Market size and forecast 2024-2029
- Chart on Kidney function tests - Market size and forecast 2024-2029 ($ billion)
- Data Table on Kidney function tests - Market size and forecast 2024-2029 ($ billion)
- Chart on Kidney function tests - Year-over-year growth 2024-2029 (%)
- Data Table on Kidney function tests - Year-over-year growth 2024-2029 (%)
- 9.4 Glucose - Market size and forecast 2024-2029
- Chart on Glucose - Market size and forecast 2024-2029 ($ billion)
- Data Table on Glucose - Market size and forecast 2024-2029 ($ billion)
- Chart on Glucose - Year-over-year growth 2024-2029 (%)
- Data Table on Glucose - Year-over-year growth 2024-2029 (%)
- 9.5 Liver function tests - Market size and forecast 2024-2029
- Chart on Liver function tests - Market size and forecast 2024-2029 ($ billion)
- Data Table on Liver function tests - Market size and forecast 2024-2029 ($ billion)
- Chart on Liver function tests - Year-over-year growth 2024-2029 (%)
- Data Table on Liver function tests - Year-over-year growth 2024-2029 (%)
- 9.6 Electrolytes - Market size and forecast 2024-2029
- Chart on Electrolytes - Market size and forecast 2024-2029 ($ billion)
- Data Table on Electrolytes - Market size and forecast 2024-2029 ($ billion)
- Chart on Electrolytes - Year-over-year growth 2024-2029 (%)
- Data Table on Electrolytes - Year-over-year growth 2024-2029 (%)
- 9.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.8 Market opportunity by Test
- Market opportunity by Test ($ billion)
- Data Table on Market opportunity by Test ($ billion)
10 Market Segmentation by End-user
- 10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Laboratories - Market size and forecast 2024-2029
- Chart on Laboratories - Market size and forecast 2024-2029 ($ billion)
- Data Table on Laboratories - Market size and forecast 2024-2029 ($ billion)
- Chart on Laboratories - Year-over-year growth 2024-2029 (%)
- Data Table on Laboratories - Year-over-year growth 2024-2029 (%)
- 10.4 Hospital - Market size and forecast 2024-2029
- Chart on Hospital - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospital - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospital - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital - Year-over-year growth 2024-2029 (%)
- 10.5 Point-of-care testing - Market size and forecast 2024-2029
- Chart on Point-of-care testing - Market size and forecast 2024-2029 ($ billion)
- Data Table on Point-of-care testing - Market size and forecast 2024-2029 ($ billion)
- Chart on Point-of-care testing - Year-over-year growth 2024-2029 (%)
- Data Table on Point-of-care testing - Year-over-year growth 2024-2029 (%)
- 10.6 Emergency departments - Market size and forecast 2024-2029
- Chart on Emergency departments - Market size and forecast 2024-2029 ($ billion)
- Data Table on Emergency departments - Market size and forecast 2024-2029 ($ billion)
- Chart on Emergency departments - Year-over-year growth 2024-2029 (%)
- Data Table on Emergency departments - Year-over-year growth 2024-2029 (%)
- 10.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.8 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.4 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.4.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.4.2 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.4.3 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.4.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.4.5 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 12.4.6 Thailand - Market size and forecast 2024-2029
- Chart on Thailand - Market size and forecast 2024-2029 ($ billion)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ billion)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- 12.4.7 Singapore - Market size and forecast 2024-2029
- Chart on Singapore - Market size and forecast 2024-2029 ($ billion)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ billion)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- 12.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.5.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.5.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.5.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.5.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.5.5 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 12.5.6 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.5.7 Russia - Market size and forecast 2024-2029
- Chart on Russia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Russia - Market size and forecast 2024-2029 ($ billion)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 12.6.2 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.6.3 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.6.4 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.6.6 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Escalating incidence of chronic diseases
- Expanding geriatric population
- Technological advancements in diagnostic and laboratory automation
- 13.2 Market challenges
- Stringent regulatory frameworks and compliance burdens
- Complex reimbursement policies and increasing pricing pressures
- Navigating shift towards point-of-care testing and associated data privacy concerns
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Ascendancy of point-of-care metabolic panel testing
- Integration of artificial intelligence in metabolic panel analysis
- Expansion of at-home and direct-to-consumer metabolic panel testing
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 ARUP Laboratories
- ARUP Laboratories - Overview
- ARUP Laboratories - Product / Service
- ARUP Laboratories - Key offerings
- SWOT
- 15.6 Beckman Coulter Inc.
- Beckman Coulter Inc. - Overview
- Beckman Coulter Inc. - Product / Service
- Beckman Coulter Inc. - Key offerings
- SWOT
- 15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.8 CENTOGENE NV
- CENTOGENE NV - Overview
- CENTOGENE NV - Product / Service
- CENTOGENE NV - Key offerings
- SWOT
- 15.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.10 Laboratory Corp.
- Laboratory Corp. - Overview
- Laboratory Corp. - Business segments
- Laboratory Corp. - Key news
- Laboratory Corp. - Key offerings
- Laboratory Corp. - Segment focus
- SWOT
- 15.11 Mayo Medical Laboratories
- Mayo Medical Laboratories - Overview
- Mayo Medical Laboratories - Product / Service
- Mayo Medical Laboratories - Key offerings
- SWOT
- 15.12 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
- 15.13 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Business segments
- QuidelOrtho Corp. - Key offerings
- QuidelOrtho Corp. - Segment focus
- SWOT
- 15.14 Randox Laboratories Ltd.
- Randox Laboratories Ltd. - Overview
- Randox Laboratories Ltd. - Product / Service
- Randox Laboratories Ltd. - Key news
- Randox Laboratories Ltd. - Key offerings
- SWOT
- 15.15 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.16 Sonic Healthcare Ltd.
- Sonic Healthcare Ltd. - Overview
- Sonic Healthcare Ltd. - Business segments
- Sonic Healthcare Ltd. - Key offerings
- Sonic Healthcare Ltd. - Segment focus
- SWOT
- 15.17 SYNLAB International GmbH
- SYNLAB International GmbH - Overview
- SYNLAB International GmbH - Product / Service
- SYNLAB International GmbH - Key offerings
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
